Recurrence or relapse Tumor Cellular therapy Partial remission CTCAE TNM staging system Performance status Tyrosine kinase inhibitors (TKIs) Maintenance chemotherapy Active surveillance Pathological stage Neoadjuvant treatment Chemotherapy Multiple myeloma ECOG performance status Minimal residual disease Refractory Palliation Cancer Checkpoint inhibitor Liquid tumor Definitive treatment Benign Cure Carcinoma Leukemia Complementary therapy PET scan Antibody drug conjugate Surgical margin Sarcoma Monoclonal antibody Adenocarcinoma Lymphoma Complete remission Grade 3, 4, or 5 Clinical stage Adjuvant treatment Recurrence or relapse Tumor Cellular therapy Partial remission CTCAE TNM staging system Performance status Tyrosine kinase inhibitors (TKIs) Maintenance chemotherapy Active surveillance Pathological stage Neoadjuvant treatment Chemotherapy Multiple myeloma ECOG performance status Minimal residual disease Refractory Palliation Cancer Checkpoint inhibitor Liquid tumor Definitive treatment Benign Cure Carcinoma Leukemia Complementary therapy PET scan Antibody drug conjugate Surgical margin Sarcoma Monoclonal antibody Adenocarcinoma Lymphoma Complete remission Grade 3, 4, or 5 Clinical stage Adjuvant treatment
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Recurrence or relapse
Tumor
Cellular therapy
Partial remission
CTCAE
TNM staging system
Performance status
Tyrosine kinase inhibitors (TKIs)
Maintenance chemotherapy
Active surveillance
Pathological stage
Neoadjuvant treatment
Chemotherapy
Multiple myeloma
ECOG performance status
Minimal residual disease
Refractory
Palliation
Cancer
Checkpoint inhibitor
Liquid tumor
Definitive treatment
Benign
Cure
Carcinoma
Leukemia
Complementary therapy
PET scan
Antibody drug conjugate
Surgical margin
Sarcoma
Monoclonal antibody
Adenocarcinoma
Lymphoma
Complete remission
Grade 3, 4, or 5
Clinical stage
Adjuvant treatment